Alice Morigi

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

Beatrice Casadei, Lisa Argnani, Serafina Guadagnuolo et al. · Cancers · 2021 · 35 citations · Full text

Medicine, Immunology, Oncology +16

Spinal Infection Multidisciplinary Management Project (SIMP): From Diagnosis to Treatment Guideline

Alessandro Gasbarrini, Luca Boriani, Cristina Nanni et al. · International Journal of Immunopathology and Pharmacology · 2011 · 34 citations

Medicine, Infectious Diseases, Orthopaedic Surgery +17

Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma

Beatrice Casadei, Lisa Argnani, Alice Morigi et al. · Cancer Medicine · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years

Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni et al. · Cancer Medicine · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Letizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei et al. · The Oncologist · 2016 · 17 citations · Full text

Medicine, Hematology, Oncology +16